Business Description
vTv Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US9183851057
Share Class Description:
VTVT: Class ADescription
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.86 | |||||
| Equity-to-Asset | -2.24 | |||||
| Debt-to-Equity | -0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.7 | |||||
| 3-Year EPS without NRI Growth Rate | -10.5 | |||||
| 3-Year FCF Growth Rate | 15.7 | |||||
| 3-Year Book Growth Rate | 41.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.71 | |||||
| 9-Day RSI | 53.94 | |||||
| 14-Day RSI | 58.2 | |||||
| 6-1 Month Momentum % | 23.43 | |||||
| 12-1 Month Momentum % | -29.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.6 | |||||
| Shareholder Yield % | 0.33 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -91.68 | |||||
| ROIC % | -324.57 | |||||
| ROC (Joel Greenblatt) % | -5644.41 | |||||
| ROCE % | -202.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.95 | |||||
| EV-to-EBITDA | -1.95 | |||||
| EV-to-Forward-Revenue | 29.28 | |||||
| EV-to-FCF | -2.65 | |||||
| Earnings Yield (Greenblatt) % | -51.28 | |||||
| FCF Yield % | -31.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VTVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
vTv Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -9.71 | ||
| Beta | 0.72 | ||
| Volatility % | 128.73 | ||
| 14-Day RSI | 58.2 | ||
| 14-Day ATR ($) | 1.770827 | ||
| 20-Day SMA ($) | 24.514095 | ||
| 12-1 Month Momentum % | -29.74 | ||
| 52-Week Range ($) | 7.38 - 39.6 | ||
| Shares Outstanding (Mil) | 2.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
vTv Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
vTv Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
vTv Therapeutics Inc Frequently Asked Questions
What is vTv Therapeutics Inc(VTVT)'s stock price today?
The current price of VTVT is $24.98. The 52 week high of VTVT is $39.60 and 52 week low is $7.38.
When is next earnings date of vTv Therapeutics Inc(VTVT)?
The next earnings date of vTv Therapeutics Inc(VTVT) is 2024-05-10 Est..
Does vTv Therapeutics Inc(VTVT) pay dividends? If so, how much?
vTv Therapeutics Inc(VTVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers